Stock information

General information

Total Shares Issued (as of January 31, 2019) 31,839,572
Designated Sponsor/Market Maker: Oddo Seydler Bank AG
Reuters: MORG.DE
Bloomberg MOR:GR

listing in Germany

Stock Exchange: Frankfurt, Germany (Prime Standard)
Index: MDAX & TecDAX
SE Code: MOR
Security Code Number: 663 200
ISIN (International Security Identification Number): DE0006632003
1st Trading Day: March 9, 1999 (Neuer Markt)

Listing in the u.s.

Stock Exchange: Nasdaq
SE Code: MOR
CUSIP: 61776020
1st Trading Day: April 19, 2018
Security Paper: American Depositary Shares (ADS)
Ratio: 4 ADS = 1 Ordinary Share


Stock charts

Share price performance

MorphoSys AG shares opened the reporting year at a share price of € 48.75. After a volatile start in the first weeks of 2017, the shares marked their low for the year on February 6 at € 47.60. The shares then trended higher in line with the TecDAX before breaking out in September with price performance far outpacing the benchmark index. Positive news flow, such as the breakthrough therapy status for MOR208 from the FDA and the approval of Tremfya® received by Janssen in new regions, drove MorphoSys shares to a high of € 82.95 on November 21. The shares closed the financial year at € 76.58, amounting to a significant share price increase of 57 % and market capitalization of € 2.3 billion. In a record year for German and international stock indices, the shares of MorphoSys AG still outperformed with a 57 % increase in share price. The NASDAQ Biotechnology Index ended the year 22 % higher, and the TecDAX rose 40 % for the year.

Liquidity and Index Membership

The average daily trading volume in MorphoSys shares on all regulated trading platforms increased by 61 % in 2017, reaching a volume of € 15.6 million (2016: € 9.7 million). The average daily trading volume on the TecDAX, which contains the 30 largest technology stocks on the Frankfurt Stock Exchange, rose 46 % amid the overall positive stock market environment. By the end of 2017, MorphoSys ranked 10th in the TecDAX in terms of market capitalization (2016: 11th) and 12th in terms of trading volume (2016: 11th). The average daily trading volume in MorphoSys shares on alternative trading platforms (“dark pools”) in 2017 was approximately € 6.3 million, or 98,700 shares (2016: approx. 103,700 shares valued at €  4.4 million), representing a year-on-year decline of 5 %.


Key data for the MorphoSys Share (As of December 31)

  2017 2016 2015 2014 2013 2012
Total stockholders´ equity (in million €) 259,7 415.5 362.7 348.8 352.1 202.0
Number of shares issued (number) 29,420,785 29,159,770 26,537,682 26,456,834 26,220,882 23,358,228
Market capitalization (in million €) 2,253 1,422 1,530 2,027 1,464 685
Closing price in € (Xetra) 76,58 48.75 57.65 76.63 55.85 29.30
Average daily trading volume (in million €) 15,6 9.7 14.9 11.9 6.9 1.9
Average daily trading volume (in % of common stock) 0,83 0.78 0.87 0.65 0.59 0.38

Recent voting rights notifications


Institution Contact
Berenberg Ms. Klara Fernandes
Bloomberg Intelligence Ms. Cinney Zhang
Bryan Garnier Mr. Gary Waanders
Commerzbank Mr. Daniel Wendorff
Deutsche Bank Mr. Gunnar Romer
EQUI.TS Mr. Thomas Schießle
Goldman Sachs Mr. Graig Suvannavejh       
HSBC Bank Mr. Steve McGarry
Independent Research GmbH Mr. Sven Diermeier
JMP Securities Mr. Jason Butler
J.P.Morgan Cazenove Mr. James Gordon
Kempen & Co. Ms. Anastasia Karpova
Landesbank Baden-Württemberg Mr. Timo Kürschner
Leerink Mr. Geoffrey Porges
Piper Jaffray Ms. Danielle Brill
Royal Bank of Canada Ms. Zoe Karamanoli


Any opinions, forecasts, estimates, projections or predictions regarding MorphoSys’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of MorphoSys or its management. By providing the names of the analysts or certain information from them, MorphoSys does not imply its endorsement of or concurrence with their reports, conclusions or recommendations. MorphoSys assumes no liability for the accuracy of such information and undertakes no obligation to update it if it is not aware of changes.


American Depositary Shares



Security Paper: American Depositary Shares (ADS)
Ratio: 4 ADSs = 1 ordinary share
U.S. Security Code (Cusip): 617760202
Trading Symbol: MOR
Depositary Bank: The Bank of New York
Local Custodian Bank: The Bank of New York Mellon SANV

ADS administration

All enquiries on ADS holdings should be made to:

BNY Mellon Shareowner Services
PO Box 505000
Louisville, KY 40233-5000
Phone: +1 201 680 6825
Toll free (in the US): +1-888-BNY-ADRS (+1-888-269-2377)

Share Buy-Back

Share Buy-Back March 2016

The Management Board of MorphoSys AG announced on February 24, 2016 with the approval of the Supervisory Board the decision to repurchase its own shares over the stock market for a total purchase price of up to EUR 2.18 million (excluding ancillary costs). The share buy-back will take place between March 3 and March 10, 2016, and is based on the authorization of the Annual General Meeting on May 23, 2014. On the basis of the current share price (EUR 37.47; Xetra closing price as of February 23, 2016), the total purchasing volume amounts to up to 58,179 shares or 0.22% of the registered share capital of the Company.

The Company intends to use the shares for its long-term incentive programs for its Executive Board and the Senior Management Group, but the shares can also be used for all other legally permitted purposes stated in the authorization of the Annual General Meeting of 2014.

The relevant conditions of the shareholders' resolution passed in the Annual General Meeting 2014 on the authorization to acquire and to use its own shares shall apply. The purchase price paid per share may not be more than 10% higher or 20% lower than the Company's share price determined by the opening auction in the Xetra trading system on the day of trading.

The share buy-back has been handled independently of and uninfluenced by the Company through an appointed bank in compliance with the safe-harbor provisions.

The share buy-back program in 2016 was completed on March 4th. Thereby 52,295 shares in total were acquired.


Overview Share Buy-Back Program March 2016

Date Number of Shares Average Price in € Purchased Volume in €
March 3, 2016 13,043 42.483 554,105.77
March 4, 2016 39,252 41.421 1,625,857.09
Total 52,295 41.686 2,179,962.86